The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)
The landscape of treatment for first-line therapy in advanced urothelial cancer (aUC) and metastatic urothelial cancer (mUC) has rapidly changed in the last year alone. Maintenance avelumab remains a viable treatment option for many patients across the globe for those who have responded or have achi...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Open Exploration Publishing Inc.
2024-07-01
|
| Serija: | Exploration of Targeted Anti-tumor Therapy |
| Teme: | |
| Online pristup: | https://www.explorationpub.com/Journals/etat/Article/1002258 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|